Javascript must be enabled to continue!
Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine
View through CrossRef
The PorA protein from Neisseria meningitidis, a potential vaccine candidate, induces human bactericidal antibodies which are serosubtype specific. We developed a hexavalent PorA outer membrane vesicle vaccine based on reference strain H44/76. This vaccine contains the six most prevalent PorA serosubtypes as found in many countries. We previously reported on the immune responses of 20 adult volunteers after a single immunization with this vaccine. In this study, the B- and T-cell responses in three adult volunteers were studied after three consecutive immunizations (0, 2, and 11 months). The first immunization induced a strong B-cell response resulting in high immunoglobulin G levels in an outer membrane vesicle enzyme-linked immunosorbent assay. At least a fourfold increase in bactericidal activity was observed against the majority (four to six) of the vaccine antigens compared to prevaccination titers. Immunodominance was observed for one or two of the PorAs in the bactericidal assay with a set of six isogenic H44/76-derived PorA target strains. These strains carry the individual PorAs as present in the vaccine. The second and third immunizations did not induce a further increase in the immune responses. A decline in time with respect to PorA-specific antibodies was observed after each immunization. These observations were reflected by the T-cell proliferation responses. Two additional sets of isogenic H44/76-derived mutant strains were used to study the specificity and/or cross-reactivity of the induced bactericidal antibodies. These target strains differ only in expressing mutant family variants of either PorA P1.7,16 or P1.5,10, both present in the PorA vesicle vaccine. The bactericidal antibody responses found were directed predominantly against the P1.7 (loop 1 of P1.7,16) and the P1.10 (loop 4 of P1.5,10) epitopes. This indicates that different portions of PorA were involved in the induction of bactericidal antibodies depending upon the PorA serosubtype.
American Society for Microbiology
Title: Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine
Description:
The PorA protein from Neisseria meningitidis, a potential vaccine candidate, induces human bactericidal antibodies which are serosubtype specific.
We developed a hexavalent PorA outer membrane vesicle vaccine based on reference strain H44/76.
This vaccine contains the six most prevalent PorA serosubtypes as found in many countries.
We previously reported on the immune responses of 20 adult volunteers after a single immunization with this vaccine.
In this study, the B- and T-cell responses in three adult volunteers were studied after three consecutive immunizations (0, 2, and 11 months).
The first immunization induced a strong B-cell response resulting in high immunoglobulin G levels in an outer membrane vesicle enzyme-linked immunosorbent assay.
At least a fourfold increase in bactericidal activity was observed against the majority (four to six) of the vaccine antigens compared to prevaccination titers.
Immunodominance was observed for one or two of the PorAs in the bactericidal assay with a set of six isogenic H44/76-derived PorA target strains.
These strains carry the individual PorAs as present in the vaccine.
The second and third immunizations did not induce a further increase in the immune responses.
A decline in time with respect to PorA-specific antibodies was observed after each immunization.
These observations were reflected by the T-cell proliferation responses.
Two additional sets of isogenic H44/76-derived mutant strains were used to study the specificity and/or cross-reactivity of the induced bactericidal antibodies.
These target strains differ only in expressing mutant family variants of either PorA P1.
7,16 or P1.
5,10, both present in the PorA vesicle vaccine.
The bactericidal antibody responses found were directed predominantly against the P1.
7 (loop 1 of P1.
7,16) and the P1.
10 (loop 4 of P1.
5,10) epitopes.
This indicates that different portions of PorA were involved in the induction of bactericidal antibodies depending upon the PorA serosubtype.
Related Results
Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine
Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine
A set of isogenic strains was constructed from the meningococcal reference strain H44/76 (B:15:P1.7,16) which differed only in their outer membrane protein (OMP) compositions. Firs...
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
Procedure for Western blot v1
Procedure for Western blot v1
Goal: This document has the objective of standardizing the protocol for Western blot. This technique allows the detection of specific proteins separated on polyacrylamide gel and t...
Immunogenicity and protective capacity of a CpG ODN adjuvanted alum adsorbed bivalent meningococcal outer membrane vesicle vaccine
Immunogenicity and protective capacity of a CpG ODN adjuvanted alum adsorbed bivalent meningococcal outer membrane vesicle vaccine
Abstract
Invasive meningococcal disease (IMD) is caused by Neisseria meningitidis, with the main serogroups responsible for the disease being A, B, C, W, X, and Y. T...
2724. Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Healthy Meningococcal Vaccine-Naïve Children (2–9 Years)
2724. Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Healthy Meningococcal Vaccine-Naïve Children (2–9 Years)
Abstract
Background
MenACYW-TT is an investigational quadrivalent meningococcal conjugate vaccine that contains tetanus toxoid a...
Safety and Immunogenicity of a Meningococcal Quadrivalent Conjugate Vaccine in Five- to Eight-Year-Old Saudi Arabian Children Previously Vaccinated with Two Doses of a Meningococcal Quadrivalent Polysaccharide Vaccine
Safety and Immunogenicity of a Meningococcal Quadrivalent Conjugate Vaccine in Five- to Eight-Year-Old Saudi Arabian Children Previously Vaccinated with Two Doses of a Meningococcal Quadrivalent Polysaccharide Vaccine
ABSTRACTSaudi Arabian children respond poorly to 2 doses of meningococcal quadrivalent polysaccharide vaccine (MPSV4) when given before 2 years of age. This study examined whether ...
An Investigation into Hydrophobic Membrane Fouling in Desalination Using Membrane Distillation Technology
An Investigation into Hydrophobic Membrane Fouling in Desalination Using Membrane Distillation Technology
Demand for freshwater supplies is continuously increasing globally to the extent where some parts of the world became highly water stressed. In particular, the Arabian Gulf states ...
Sociocultural and geographical disparities in immunization among different geographical regions of Maharashtra
Sociocultural and geographical disparities in immunization among different geographical regions of Maharashtra
Abstract
Background
In Maharashtra, child immunization is an essential factor in maternal and child health services and effective in reduced child morbidity and mortality....

